Do lacunar strokes benefit from thrombolysis? Evidence from the registry of the canadian stroke network

International Journal of Stroke

Volumn 8, Issue 100 A, 2013, Pages 45-49

  Shobha, Nandavar ^a   Fang, Jiming ^b   Hill, Michael D ^c  

^a Vikram Hospital   (India)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Lacunar strokes; OCSP; Oxfordshire Community Stroke Project; Thrombolysis

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; DISEASE REGISTRY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; PRIORITY JOURNAL; RANKIN SCALE; STROKE PATIENT; CASE STUDY; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; HOSPITAL DISCHARGE; MORTALITY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TREATMENT RESPONSE;

LACUNAR STROKES; OCSP; OXFORDSHIRE COMMUNITY STROKE PROJECT; THROMBOLYSIS;

AGED; ANTICOAGULANTS; CASE-CONTROL STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; STROKE, LACUNAR; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84886296471     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2012.00932.x     Document Type: Article

References (28)

1. Bamford J, Sandercock P, Jones L, Warlow C. The natural history of lacunar infarction: the Oxfordshire Community Stroke Project. Stroke 1987; 18:545-551.
2. Norrving B. Long-term prognosis after lacunar infarction. Lancet Neurol 2003; 2:238-245.
3. Norrving B. Lacunar infarcts: no black holes in the brain are benign. Pract Neurol 2008; 8:222-228.
4. Fisher CM. The arterial lesions underlying lacunes. Acta Neuropathol 1968; 12:1-15.
5. Fisher CM. Lacunar strokes and infarcts: a review. Neurology 1982; 32:871-876.
6. Futrell N, Garcia JH, Peterson E, Millikan C. Embolic stroke in aged rats. Stroke 1991; 22:1582-1591.
7. Futrell N, Watson BD, Dietrich WD, Prado R, Millikan C, Ginsberg MD. A new model of embolic stroke produced by photochemical injury to the carotid artery in the rat. Ann Neurol 1988; 23:251-257.
8. Millikan C, Futrell N. The fallacy of the lacune hypothesis. Stroke 1990; 21:1251-1257.
9. Rapp JH, Hollenbeck K, Pan XM. An experimental model of lacunar infarction: embolization of microthrombi. J Vasc Surg 2008; 48:196-200.
10. Toni D, Iweins F, von Kummer R etal. Identification of lacunar infarcts before thrombolysis in the ECASS I study. Neurology 2000; 54:684-688.
11. Yamada M, Yoshimura S, Kaku Y etal. Prediction of neurologic deterioration in patients with lacunar infarction in the territory of the lenticulostriate artery using perfusion CT. AJNR Am J Neuroradiol 2004; 25:402-408.
12. The NINDS Stroke tPA Study Group. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333:1581-1587.
13. The NINDS Stroke tPA Study Group. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Experience. Ann Emerg Med 2005; 46:243-252.
14. Hsia AW, Sachdev HS, Tomlinson J, Hamilton SA, Tong DC. Efficacy of IV tissue plasminogen activator in acute stroke: does stroke subtype really matter? Neurology 2003; 61:71-75.
15. Cocho D, Belvis R, Marti-Fabregas J etal. Does thrombolysis benefit patients with lacunar syndrome? Eur Neurol 2006; 55:70-73.
16. Saposnik G, Hill MD, O'Donnell M, Fang J, Hachinski V, Kapral MK. Variables associated with 7-day, 30-day, and 1-year fatality after ischemic stroke. Stroke 2008; 39:2318-2324.
17. Bamford J, Dennis M, Sandercock P, Burn J, Warlow C. The frequency, causes and timing of death within 30 days of a first stroke: the Oxfordshire Community Stroke Project. J Neurol Neurosurg Psychiatry 1990; 53:824-829.
18. Fiorelli M, Bastianello S, von Kummer R etal. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 1999; 30:2280-2284.
19. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004; 159:702-706.
20. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 2005; 162:199-200.
21. Hacke W, Kaste M, Fieschi C etal. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998; 352:1245-1251.
22. The NINDS Stroke tPA Study Group. Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 1997; 28:2119-2125.
23. Khatri P, Kleindorfer DO, Yeatts SD etal. Strokes with minor symptoms: an exploratory analysis of the national institute of neurological disorders and stroke recombinant tissue plasminogen activator trials. Stroke 2010; 41:2581-2586.
24. Inzitari D, Eliasziw M, Sharpe BL, Fox AJ, Barnett HJ. Risk factors and outcome of patients with carotid artery stenosis presenting with lacunar stroke. North American Symptomatic Carotid Endarterectomy Trial Group. Neurology 2000; 54:660-666.
25. Wardlaw JM. What causes lacunar stroke? J Neurol Neurosurg Psychiatry 2005; 76:617-619.
26. Staaf G, Geijer B, Lindgren A, Norrving B. Diffusion-weighted MRI findings in patients with capsular warning syndrome. Cerebrovasc Dis 2004; 17:1-8.
27. Vivanco-Hidalgo RM, Rodriguez-Campello A, Ois A etal. Thrombolysis in capsular warning syndrome. Cerebrovasc Dis 2008; 25:508-510.
28. Stapf C, Hofmeister C, Hartmann A, Marx P, Mast H. Predictive value of clinical lacunar syndromes for lacunar infarcts on magnetic resonance brain imaging. Acta Neurol Scand 2000; 101:13-18.